Ninth Circuit Revives Major False Claims Act Lawsuit Over Drug Pricing in the 340B Program
March 20, 2026 | Posted By: Sean Estes
On March 17, 2026, the U.S. Court of Appeals for the Ninth Circuit issued a unanimous decision that could reshape how whistleblowers fight pharmaceutical fraud. In U.S. ex rel. Adventist Health System of West v. AbbVie Inc., the court reversed a district court dismissal and cleared the way for a hospital system to pursue False […]
Learn More